Clinical Trial Update: Beta-cell Function in Glucose Abnormalities and Acute Myocardial Infarction [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating beta-cell function in glucose abnormalities related to myocardial infarction and unstable angina. Completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Impaired Glucose Tolerance
• Myocardial Infarction
• Unstable Angina Pectoris

Snippet

Sponsor: Karolinska Institutet | Conditions: Myocardial Infarction, Unstable Angina Pectoris | Phase 4 | Status: COMPLETED